Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approach

BackgroundBiological effects of nuclear factor-κB (NFκB) can differ tremendously depending on the cellular context. For example, NFκB induced by interleukin-1 (IL-1) is converted from an inhibitor of death receptor induced apoptosis into a promoter of ultraviolet-B radiation (UVB)-induced apoptosis. This conversion requires prolonged NFκB activation and is facilitated by IL-1 + UVB-induced abrogation of the negative feedback loop for NFκB, involving a lack of inhibitor of κB (IκBα) protein reappearance. Permanent activation of the upstream kinase IKKβ results from UVB-induced inhibition of the catalytic subunit of Ser-Thr phosphatase PP2A (PP2Ac), leading to immediate phosphorylation and degradation of newly synthesized IκBα.ResultsTo investigate the mechanism underlying the general PP2A-mediated tuning of IKKβ phosphorylation upon IL-1 stimulation, we have developed a strictly reduced mathematical model based on ordinary differential equations which includes the essential processes concerning the IL-1 receptor, IKKβ and PP2A. Combining experimental and modelling approaches we demonstrate that constitutively active, but not post-stimulation activated PP2A, tunes out IKKβ phosphorylation thus allowing for IκBα resynthesis in response to IL-1. Identifiability analysis and determination of confidence intervals reveal that the model allows reliable predictions regarding the dynamics of PP2A deactivation and IKKβ phosphorylation. Additionally, scenario analysis is used to scrutinize several hypotheses regarding the mode of UVB-induced PP2Ac inhibition. The model suggests that down regulation of PP2Ac activity, which results in prevention of IκBα reappearance, is not a direct UVB action but requires instrumentality.ConclusionThe model developed here can be used as a reliable building block of larger NFκB models and offers comprehensive simplification potential for future modeling of NFκB signaling. It gives more insight into the newly discovered mechanisms for IKK deactivation and allows for substantiated predictions and investigation of different hypotheses. The evidence of constitutive activity of PP2Ac at the IKK complex provides new insights into the feedback regulation of NFκB, which is crucial for the development of new anti-cancer strategies.

[1]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[2]  Michael Karin,et al.  NF-kappaB in cancer: a marked target. , 2003, Seminars in cancer biology.

[3]  Dagmar Kulms,et al.  NFκB-dependent Down-regulation of Tumor Necrosis Factor Receptor-associated Proteins Contributes to Interleukin-1-mediated Enhancement of Ultraviolet B-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[4]  O. Sawodny,et al.  Modeling of IL-1 induced NF-κB signaling and analysis of additional UVB influence , 2007, SICE Annual Conference 2007.

[5]  Andre Levchenko,et al.  Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.

[6]  Thomas A. Luger,et al.  Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95-induced Apoptosis but Not from Ultraviolet Radiation-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[7]  Andre Levchenko,et al.  Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. , 2006, The Journal of biological chemistry.

[8]  Alexander Hoffmann,et al.  Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.

[9]  Michael Karin,et al.  The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.

[10]  S C Sun,et al.  Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. , 1995, The Journal of biological chemistry.

[11]  Rosario Perona,et al.  The role of the NFκB signalling pathway in cancer , 2008 .

[12]  Céline Gélinas,et al.  Rel/NF-?B and I?B factors in oncogenesis , 1997 .

[13]  G P Nolan,et al.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. , 1993, Genes & development.

[14]  Masao Omata,et al.  Inflammation and cancer: Role of nuclear factor‐kappaB activation , 2008, Cancer science.

[15]  H. Walczak,et al.  Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor , 2008, Cell Death and Differentiation.

[16]  Jens Timmer,et al.  Dynamical modeling and multi-experiment fitting with PottersWheel , 2008, Bioinform..

[17]  Michael Karin,et al.  NF-κB in cancer: a marked target , 2003 .

[18]  H. Pahl,et al.  Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.

[19]  M. Karin,et al.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.

[20]  A. Ullrich,et al.  Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. , 1996, The EMBO journal.

[21]  S J Sung,et al.  Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors. , 1993, The Journal of biological chemistry.

[22]  Rosario Perona,et al.  The role of the NFkappaB signalling pathway in cancer. , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[23]  Marek Kimmel,et al.  Mathematical model of NF-kappaB regulatory module. , 2004, Journal of theoretical biology.

[24]  Marek Kimmel,et al.  Mathematical model of NF- κB regulatory module , 2004 .

[25]  L. O’Neill,et al.  Signal transduction pathways activated by the IL‐1 receptor family: ancient signaling machinery in mammals, insects, and plants , 1998, Journal of leukocyte biology.

[26]  R. Heinrich,et al.  The Regulation of Cellular Systems , 1996, Springer US.

[27]  H. Shih,et al.  Heptad Repeats Regulate Protein Phosphatase 2A Recruitment to I-κB Kinase γ/NF-κB Essential Modulator and Are Targeted by Human T-lymphotropic Virus Type 1 Tax* , 2007, Journal of Biological Chemistry.

[28]  D. Kulms,et al.  Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome , 2006, Oncogene.

[29]  E. Harhaj,et al.  Activation of NF-κB by Phosphatase Inhibitors Involves the Phosphorylation of IκBα at Phosphatase 2A-sensitive Sites (*) , 1995, The Journal of Biological Chemistry.

[30]  Sankar Ghosh,et al.  Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. , 2008, The Journal of biological chemistry.

[31]  Kwang-Hyun Cho,et al.  The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach , 2006, FEBS letters.

[32]  Jens Timmer,et al.  Data-based identifiability analysis of non-linear dynamical models , 2007, Bioinform..

[33]  H. Shih,et al.  Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax. , 2007, The Journal of biological chemistry.

[34]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[35]  C Gélinas,et al.  Rel/NF-kappa B and I kappa B factors in oncogenesis. , 1997, Seminars in cancer biology.

[36]  Gautam Sethi,et al.  Nuclear factor-kappa B: from clone to clinic. , 2007, Current molecular medicine.

[37]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[38]  Kwang-Hyun Cho,et al.  Investigations into the analysis and modeling of the TNF alpha-mediated NF-kappa B-signaling pathway. , 2003, Genome research.

[39]  N. Perkins,et al.  Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .

[40]  A. Krikos,et al.  Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.

[41]  Kwang-Hyun Cho,et al.  Investigations Into the Analysis and Modeling of the TNFα-Mediated NF-κB-Signaling Pathway , 2003 .

[42]  B. Aggarwal,et al.  Nuclear Factor-κB Activation: From Bench to Bedside , 2008 .

[43]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[44]  Michael Karin,et al.  NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.

[45]  Gautam Sethi,et al.  Nuclear factor-kappaB activation: from bench to bedside. , 2008, Experimental biology and medicine.

[46]  N. Perkins,et al.  Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. , 2004, Molecular cell.

[47]  J. Piette,et al.  Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. , 1997, Journal of immunology.

[48]  Miles Congreve,et al.  Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B , 2003, Nature.

[49]  Robert S. Carter,et al.  Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.

[50]  R. Page,et al.  Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts. , 1988, The Journal of biological chemistry.

[51]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[52]  T. Luger,et al.  Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 1998, The Journal of Biological Chemistry.